Keywords: relenza, approved, japan, record, time, glaxo, wellcome

Relenza approved in Japan in record time

Article | 29 December 1999

Print This

Glaxo Wellcome has received approval from the Japanese Ministry ofHealth and Welfare for its influenza drug Relenza (zanamivir), which is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in